Every 10-Q that Heartflow, Inc. (HTFL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HTFL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HTFL filings page.
Heartflow, Inc. reported strong top-line growth but continued losses for the quarter ended June 30, 2026. Revenue for the quarter rose to $64.1 million from $43.4 million a year earlier, driven primarily by U.S. customers, which contributed $60.3 million. Six‑month revenue increased to $116.7 million from $80.6 million.
Despite higher revenue, Heartflow posted a quarterly net loss of $15.7 million and a six‑month net loss of $43.1 million, reflecting heavy investment in research and development and selling, general and administrative activities. The company recorded a $7.5 million asset impairment tied to subleasing its Mountain View facility. Operating cash outflow was $38.7 million for the first half. Liquidity remains solid with $246.8 million in cash, cash equivalents and investments and total assets of $344.5 million against total liabilities of $64.7 million. Management states existing cash and expected revenue should fund operations for at least 12 months. As of July 31, 2026, common shares outstanding were 86.95 million.
Heartflow, Inc. reported Q3 2025 results. Revenue was $46,276 thousand with gross profit of $35,415 thousand. Operating loss was $15,099 thousand, and net loss was $50,855 thousand, driven in part by a $32,117 thousand increase in the fair value of the common stock warrant liability and a $6,360 thousand loss on extinguishment of debt.
The company completed its IPO on August 11, 2025, selling 19,166,667 shares at $19.00 per share for gross proceeds of approximately $364.2 million (net cash inflow of $332,784 thousand). All redeemable convertible preferred stock converted into 51,226,348 common shares, and 6,470,743 shares were issued upon conversion of 2025 convertible notes. A 1‑for‑2.92 reverse stock split was effected on July 31, 2025.
As of September 30, 2025, cash and cash equivalents were $291,167 thousand; the prior term loan was fully repaid (balance $0 versus $136,431 thousand at year‑end 2024). Shares outstanding were 85,158,719 as of October 31, 2025.
HeartFlow, Inc. (HTFL) reported interim financial and operational disclosures reflecting a recent reverse stock split, significant financing activity and continuing operating losses. The company completed an IPO that raised approximately $364.2 million gross proceeds (before underwriting discounts and estimated offering expenses). As of June 30, 2025, cash and cash equivalents were $80.2 million versus $51.4 million at December 31, 2024, and the company had an accumulated deficit of approximately $1.0 billion. The company issued 2025 Convertible Notes totaling $98.3 million with embedded derivative features and maintains a 2024 Term Loan with an effective interest rate of 15.2% as of June 30, 2025. The 2024 Credit Agreement contains collateral, liquidity and trailing net sales covenants, including a minimum liquidity requirement reduced to $15.0 million and a rising minimum twelve-month net sales covenant up to $110.0 million. Management states that, together with expected customer revenue and IPO proceeds, available liquidity is sufficient to fund planned operations for at least the next 12 months from the date the condensed consolidated financial statements were available to be issued.